Literature DB >> 17676640

Dynamic expression of FXYD6 in the inner ear suggests a role of the protein in endolymph homeostasis and neuronal activity.

Benjamin Delprat1, Jean-Luc Puel, Käthi Geering.   

Abstract

A key protein in the production and in the maintenance of the endocochlear potential is the Na,K-ATPase. Previously, we have shown that FXYD6 is a modulator of the Na,K-ATPase expressed in the inner ear (Delprat et al. [2007] J Biol Chem 282:7450-7456). To investigate the potential role of FXYD6 in inner ear function, we studied the developmental expression of FXYD6. Reverse transcriptase-polymerase chain reaction analysis demonstrates that FXYD6 is present as two splice variants. Both variants coimmunoprecipitate with Na,K-ATPase after expression in Xenopus oocytes. Immunohistochemistry of the cochlea (from birth to postnatal day 30) shows that FXYD6 is expressed in several epithelial cells important for endolymph homeostasis. Marked similarities were found in the developmental expression patterns of FXYD6 and Na,K-ATPase, suggesting functional cooperation between the two proteins in the generation and maintenance of the endocochlear potential and ion composition of the endolymph. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676640     DOI: 10.1002/dvdy.21269

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  4 in total

1.  Distribution of the Na,K-ATPase alpha subunit in the rat spiral ganglion and organ of corti.

Authors:  Will J McLean; K Anne Smith; Elisabeth Glowatzki; Sonja J Pyott
Journal:  J Assoc Res Otolaryngol       Date:  2008-12-12

2.  Age-Related Inflammation and Oxidative Stress in the Cochlea Are Exacerbated by Long-Term, Short-Duration Noise Stimulation.

Authors:  Verónica Fuentes-Santamaría; Juan Carlos Alvarado; Susana Mellado; Pedro Melgar-Rojas; María Cruz Gabaldón-Ull; José J Cabanes-Sanchis; José M Juiz
Journal:  Front Aging Neurosci       Date:  2022-04-05       Impact factor: 5.702

3.  FXYD6: a novel therapeutic target toward hepatocellular carcinoma.

Authors:  Qian Gao; Xiongfei Chen; Hongxia Duan; Zhaoqing Wang; Jing Feng; Dongling Yang; Lina Song; Ningxin Zhou; Xiyun Yan
Journal:  Protein Cell       Date:  2014-04-10       Impact factor: 14.870

4.  FXYD proteins and sodium pump regulatory mechanisms.

Authors:  John Q Yap; Jaroslava Seflova; Ryan Sweazey; Pablo Artigas; Seth L Robia
Journal:  J Gen Physiol       Date:  2021-04-05       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.